KBS Drama 'Sleeping Doctor' Production Contract
키이스트
054780
Signal Score
Historical Avg Return (5d)
+0.36%
Data Coverage
100%n=677
Risk-adjusted indicator based on 677 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Amount: 5.52B KRW
- • % of Recent Revenue: 35.16%
- • Advance Payment: 4B KRW
- • Contract Period: June 10, 2026 - June 15, 2027
- • Recent Annual Revenue (2025): 15.70B KRW
AI Analysis Summary
KEYEAST Co., Ltd. secured a 5.52 billion KRW contract with KBS for the outsourced production of the drama 'Sleeping Doctor'. This contract represents 35.16% of the company's recent annual revenue (15.70 billion KRW as of 2025). An advance payment of 4 billion KRW is scheduled for June 15, 2026. The contract spans from June 10, 2026, to June 15, 2027, and includes 12 episodes, each valued at 460 million KRW. This significant contract is expected to positively impact future revenue and profitability, although the revenue recognition will occur in 2026-2027.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.